Why the study?
Chronic kidney disease is a significant microvascular complication of diabetes mellitus, requiring updated recommendations for evaluation and management to prevent or slow progression.
Does annual screening and proper medical therapy prevent or slow the progression of CKD in patients with diabetes?
Does annual screening and proper medical therapy prevent or slow the progression of CKD in patients with diabetes?
Answers are grounded in this paper and cite their sources.
This review outlines strategies including screening and medical therapy to manage and slow the progression of diabetic kidney disease.
Tactics to prevent or slow progression of CKD in patients with diabetes Annual screening of urinary parameters, ongoing clinical vigilance, and proper medical therapy can help to keep declining renal function at bay. C hronic kidney disease (CKD) is a significant comorbidity of diabetes mellitus. The Kidney Disease Outcomes Quality Initiative (KDOQI) of the National Kidney Foundation defines CKD as the presence of kidney damage or decreased kidney function for 3 months. CKD caused by diabetes is called diabetic kidney disease (DKD), which is 1 of 3 principal microvascular complications of diabetes. 2] his article provides the latest recommendations for evaluating and managing DKD to help you prevent or slow its progression.
No takes yet. Share an insight, caveat, or question.
Ahmad (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: